Abstract

BackgroundWe aim to document the long-term outcomes of ischemic stroke patients and explore the potential risk factors for recurrent cardiovascular events and all-cause mortality in primary care.MethodsA retrospective cohort study performed at two general out-patient clinics (GOPCs) under Hospital Authority (HA) in Hong Kong (HK). Ischemic stroke patients with at least two consecutive follow-up visits during the recruitment period (1/1–30/6/2010) were included. Patients were followed up regularly till the date of recurrent stroke, cardiovascular event, death or 31/12/2018. The primary outcome was the occurrence of recurrent cerebrovascular event including transient ischemic stroke (TIA), ischemic stroke or hemorrhagic stroke. The secondary outcomes were all-cause mortality and coronary artery disease (CAD). We fit cox proportional hazard model adjusting death as competing risk factor to estimate the cause-specific hazard ratio (csHR).ResultsA total of 466 patients (mean age, 71.5 years) were included. During a median follow-up period of 8.7 years, 158 patients (33.9%) died. Eighty patients (17.2%) had recurrent stroke and 57 (12.2%) patients developed CAD. Age was an independent risk factor for recurrent stroke, CAD and death. Statin therapy at baseline had a protective effect for recurrent stroke (csHR = 0.476; 95% confidence interval [CI] 0.285–0.796, P = 0.005) after adjusting death as a competing risk factor and all-cause mortality (HR = 0.693, 95% CI 0.486–0.968, P = 0.043). In addition, female sex, antiplatelet and a higher diastolic blood pressure (DBP) at baseline were also independent predictors for survival.ConclusionsLong term prognosis of ischemic stroke patients in primary care is favorable. Use of statin was associated with a significant decrease in stroke recurrence and mortality. Patients who died had a significant lower DBP at baseline, highlighted the need to consider both systolic and diastolic blood pressure in our daily practice.

Highlights

  • We aim to document the long-term outcomes of ischemic stroke patients and explore the potential risk factors for recurrent cardiovascular events and all-cause mortality in primary care

  • The secondary outcomes were all-cause mortality and development of coronary artery disease (CAD), respectively. Study design This was a retrospective cohort study performed at two major General out-patient clinic (GOPC) (Lek Yuen & Ma On Shan family medicine center, New Territories East Cluster (NTEC), Hospital Authority (HA)), which served a population of 630,000 in Shatin District (8.9% of Hong Kong (HK) population)

  • Statin therapy at baseline had a protective effect for recurrent stroke and all-cause death

Read more

Summary

Introduction

We aim to document the long-term outcomes of ischemic stroke patients and explore the potential risk factors for recurrent cardiovascular events and all-cause mortality in primary care. Effective measures for secondary prevention of stroke includes lifestyle modifications, vascular risk factor control and use of antiplatelet and anticoagulant drugs. The clinical protocol of secondary stroke prevention for ischemic stroke patients [Department of Family. 2. Check blood pressure (BP) at each visit 3. BP < 130/80 mmHg for patients with diabetes 5. Check fasting blood glucose and lipids annually 6. Aim for hemoglobin A1c (­HbA1C) < 7% for patients with diabetes mellitus (DM) 7. Antiplatelet agents for patients with non-cardioembolic ischemic stroke unless contraindicated, options including aspirin /aspirin plus extended- release dipydridamole/ Clopidogrel 9. Warfarin or novel oral anticoagulant for patients with atrial fibrillation (AF) unless contraindicated

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call